SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedSeptember 2021 , the total revenue stood at Rs. 4016.10  millions.Net Profit of the company move down -45.96% to Rs. 302.30  millions from Rs. 559.40 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 756.80 millions from 1028.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 4016.10 3975.60 1.02 8071.80 7459.80 8.20 16168.80 13217.50 22.33
Other Income 35.10 56.80 -38.20 93.10 102.60 -9.26 284.10 275.10 3.27
PBIDT 756.80 1028.30 -26.40 1733.40 1908.90 -9.19 4137.40 2840.40 45.66
Interest 170.70 193.70 -11.87 359.90 392.00 -8.19 844.70 778.80 8.46
PBDT 585.30 834.60 -29.87 1366.90 1516.90 -9.89 3292.70 2061.60 59.72
Depreciation 283.00 275.20 2.83 559.00 536.60 4.17 1083.10 936.70 15.63
PBT 302.30 559.40 -45.96 807.90 980.30 -17.59 2209.60 1124.90 96.43
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -59.30 -97.70 -39.30 -147.70 -171.90 -14.08 -386.40 -206.90 86.76
PAT 302.30 559.40 -45.96 807.90 980.30 -17.59 2209.60 1124.90 96.43
Equity 359.20 358.10 0.31 359.20 358.10 0.31 359.20 268.50 33.78
PBIDTM(%) 18.84 25.87 -27.15 21.47 25.59 -16.08 25.59 21.49 19.07

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×